Health system intelligence profile
Michigan Medicine
Editorially verified · Last reviewed August 30, 2026
Intelligence summary
Mandate and remit
Michigan Medicine's Fast Forward Medical Innovation (FFMI) is an official biomedical commercialization and entrepreneurship program that describes itself as a front door to biomedical commercialization at the University of Michigan. Its public materials say FFMI provides resources, support, mentorship, funding education, and commercialization guidance to biomedical researchers, students, collaborators, and industry partners. The program page names commercialization education, mentorship and funding, corporate-partner support, the Michigan Biomedical Venture Fund, and FFMI fastPACE among its offerings. The FFMI innovation-portfolio page also lists programs including the Frankel Cardiovascular Center Innovation Program, Rogel Cancer Center Innovation Program, Innovation Studio, and intellectual-property education. This profile records the published program structure and types of support without claiming that a funded project, portfolio company, or institutional partnership achieved a particular result.
These routes appear in the program's sourced public record.
Fast Forward Medical Innovation ↗
Biomedical commercialization program offering resources, support, mentorship, education, and funding guidance for University of Michigan innovators and collaborators.
Virtual, project-based experiential course designed to help academics launch innovations such as medical devices, diagnostics, digital solutions, drugs, and research tools.
Michigan Biomedical Venture Fund ↗
Fund named on the FFMI page as investing in biomedical startup companies with University of Michigan licensed IP in therapeutics, devices, diagnostics, or health IT.
Rogel Cancer Center Innovation Program ↗
Educational initiative for faculty, clinicians, and research scientists to develop novel therapeutics and build a business case for commercialization resources.
Fund or office: Michigan Biomedical Venture Fund
The FFMI page describes investment in biomedical startup companies with University of Michigan licensed IP across therapeutics, devices, diagnostics, and health IT.
Intellectual-property and licensing education
The FFMI innovation-portfolio page lists intellectual-property education among its commercialization resources and programs.
Biomedical startup pathway
FFMI provides mentorship, funding education, and commercialization support for biomedical innovations and names a venture fund for startup companies with University of Michigan licensed IP.
Use the program's published contact route for partnership, licensing, innovation, or program inquiries.
Comparable records based on shared public taxonomy, location, or commercialization route.
Same state · Same program type · Same commercialization route
Royal Oak, Michigan
Corewell Health Innovations Office
The Innovations Office is Corewell Health's commercialization arm, housed within the Corewell Health Research Institute in Southeast Michigan, that turns employee and researcher ideas into products, services or licenses.
Nonprofit
Read the intelligence briefReviewed August 30, 2026
Same state · Same program type · Same commercialization route
Detroit, Michigan
Henry Ford Innovations
Henry Ford Innovations advances inventions developed by Henry Ford Health clinicians and researchers while also sourcing external technologies for the system.
Nonprofit
Read the intelligence briefEditorially verified · Reviewed August 30, 2026
Same state · Same program type · Same commercialization route
Detroit, Michigan
Henry Ford + MSU Innovation Fund (Henry Ford Innovations)
Henry Ford Health and Michigan State University launched a joint Innovation Hub in 2025 anchored by a $10 million venture fund, the Henry Ford + MSU Innovation Fund, managed with the MSU Research Foundation.
Nonprofit
Read the intelligence briefEditorially verified · Reviewed August 30, 2026
Same state · Same program type · Same commercialization route
Ann Arbor, Michigan
Coulter Translational Research Partnership Program
The U-M Coulter Translational Research Partnership funds collaborative projects that pair a biomedical engineering faculty member with a Michigan Medicine clinical faculty member to accelerate development and commercialization of medical devices, diagnostics and other biomedical products addressing unmet clinical needs.
Academic · Nonprofit
Read the intelligence briefReviewed August 30, 2026
Same state · Same program type · Same commercialization route
Ann Arbor, Michigan
U-M Innovation Partnerships
Innovation Partnerships is the University of Michigan's central technology transfer and commercialization unit, handling invention disclosures, patents and licenses for the entire university including Michigan Medicine's clinical and biomedical research.
Academic · Nonprofit
Read the intelligence briefReviewed August 30, 2026
Same state · Same program type · Same commercialization route
Ann Arbor, Michigan
Michigan Biomedical Venture Fund
The Michigan Biomedical Venture Fund is an early-stage investment program within Fast Forward Medical Innovation at the University of Michigan Medical School.
Academic · Nonprofit
Read the intelligence briefEditorially verified · Reviewed August 30, 2026
Reviewed August 30, 2026. External source links open in a new tab.
Confidential comparison
Request a confidential conversation about the commercial opportunities, market pathways, and capabilities within your hospital's innovation portfolio. The public directory does not score or rank programs.